Use of Guidelines and Risk Stratification in Acute Exacerbations of Chronic Obstructive Pulmonary Disease

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Seminars in Respiratory and Critical Care Medicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/s-2000-9932PMID 16088725
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Smoking, socioeconomic status, and chronic respiratory disease.

  2015cited by this paper
• Acute exacerbation of COPD: factors associated with poor treatment outcome.

  2000cited by this paper
• Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease.

  1999cited by this paper
• Risk factors for lower airway bacterial colonization in chronic bronchitis.

  1999cited by this paper
• Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease.

  1999cited by this paper
• Treatment cost of acute exacerbations of chronic bronchitis.

  1999cited by this paper
• Airways microbial flora in COPD patients in stable clinical conditions and during exacerbations: a bronchoscopic investigation.

  1998cited by this paper
• Consenso latinoamericano sobre infecciones en bronquitis crónica

  1998cited by this paper
• A 1-year community-based health economic study of ciprofloxacin vs usual antibiotic treatment in acute exacerbations of chronic bronchitis: the Canadian Ciprofloxacin Health Economic Study Group.

  1998cited by this paper
• Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study

  1997cited by this paper
• Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. The Laboratory Investigator Group.

  1997cited by this paper
• Guidelines for the treatment of acute exacerbations of chronic bronchitis.

  1997cited by this paper
• Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians.

  1997cited by this paper
• Bacterial colonization of distal airways in healthy subjects and chronic lung disease: a bronchoscopic study.

  1997cited by this paper
• Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease.

  1996cited by this paper
• Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group.

  1996cited by this paper
• Initial antibiotic therapy for lower respiratory tract infection in the community: a European survey.

  1996cited by this paper
• Lower respiratory tract infections in the community: towards a more rational approach.

  1996cited by this paper
• Prevalence of antimicrobial resistance among 723 outpatient clinical isolates of Moraxella catarrhalis in the United States in 1994 and 1995: results of a 30-center national surveillance study

  1996cited by this paper
• Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study

  1996cited by this paper
• Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush.

  1995cited by this paper
• Outcome predictors in bronchitis.

  1995cited by this paper
• Acute infective exacerbations of chronic bronchitis.

  1995cited by this paper
• Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis.

  1995cited by this paper
• Hospital and 1-Year Survival of Patients Admitted to Intensive Care Units With Acute Exacerbation of Chronic Obstructive Pulmonary Disease

  1995cited by this paper
• Relation between beta-lactamase producing bacteria and patient characteristics in chronic obstructive pulmonary disease (COPD).

  1995cited by this paper
• Antibiotics in chronic obstructive pulmonary disease

  1994cited by this paper
• Prospective study of aetiology and outcome of adult lower-respiratory-tract infections in the community.

  1993cited by this paper
• Inhibition of human neutrophil migration in vitro by low-molecular-mass products of nontypeable Haemophilus influenzae

  1993cited by this paper
• Survival of patients with chronic obstructive pulmonary disease receiving long-term domiciliary oxygen therapy.

  1993cited by this paper
• Respiratory tract infections: when is antibiotic therapy indicated?

  1991cited by this paper
• Treatment of acute exacerbations of chronic bronchitis: state of the art.

  1991cited by this paper
• Effects of human neutrophil elastase and Pseudomonas aeruginosa proteinases on human respiratory epithelium.

  1991cited by this paper
• Endogenous and exogenous reinfections by Haemophilus influenzae in patients with chronic obstructive pulmonary disease: the effect of antibiotic treatment on persistence.

  1990cited by this paper
• Effect of bacterial products on neutrophil migration in vitro.

  1990cited by this paper
• Prognosis in chronic obstructive pulmonary disease.

  1990cited by this paper
• Effect of Streptococcus pneumoniae on human respiratory epithelium in vitro

  1989cited by this paper
• Host-Microbial Interrelationships in Respiratory Infection

  1989cited by this paper
• Frequency of fimbriation of nontypable Haemophilus influenzae and its ability to adhere to chinchilla and human respiratory epithelium

  1988cited by this paper
• Pyocyanin and 1-hydroxyphenazine produced by Pseudomonas aeruginosa inhibit the beating of human respiratory cilia in vitro.

  1987cited by this paper
• Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.

  1987cited by this paper
• Indium-111-labelled granulocyte accumulation in respiratory tract of patients with bronchiectasis.

  1987cited by this paper
• Bacterial colonization: pathogenesis and clinical significance.

  1987cited by this paper
• Synthesis of histamine by Haemophilus influenzae.

  1986cited by this paper
• Bacteria associated with obstructive pulmonary disease elaborate extracellular products that stimulate mucin secretion by explants of guinea pig airways.

  1986cited by this paper
• Pathogenesis of IgA1 protease-producing and -nonproducing Haemophilus influenzae in human nasopharyngeal organ cultures.

  1986cited by this paper
• Adherence of Pseudomonas aeruginosa to human tracheobronchial mucin

  1984cited by this paper
• Fimbriation of Haemophilus species isolated from the respiratory tract of adults.

  1984cited by this paper
• Inhibition of human polymorphonuclear leukocyte respiratory burst, bactericidal activity, and migration by pneumolysin

  1983cited by this paper
• Serum derived protease inhibitors and leucocyte elastase in sputum and the effect of infection.

  1980cited by this paper
• Role of infection in chronic bronchitis.

  1976cited by this paper
• Role of infection in chronic bronchitis.

  1975cited by this paper
• Prognosis in chronic obstructive pulmonary disease.

  1973cited by this paper
• Expressions of morbidity in general practice.

  1971cited by this paper

• Antibiotic Therapy for Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)

  2010cites this paper
• Soluble ST2 plasma concentrations predict 1-year mortality in acutely dyspneic emergency department patients with pulmonary disease.

  2008cites this paper
• Living with chronic obstructive pulmonary disease: The experience of patients and their carers.

  2007cites this paper
• Chronic Obstructive Pulmonary Disease Exacerbation

  2004cites this paper
• A comparison of 5-day courses of dirithromycin and azithromycin in the treatment of acute exacerbations of chronic obstructive pulmonary disease.

  2003cites this paper
• [Antibiotics policy in primary and specialist care. Two separate policies?].

  2002cites this paper
• Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey

  2002cites this paper
• Política de antibióticos en atención primaria y especializada. ¿Dos políticas alejadas?

  2002cites this paper
• The Chronic Obstructive Pulmonary Disease Exacerbation

  2000cites this paper